Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Feb;52(2):103–106. doi: 10.1136/jcp.52.2.103

Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.

C De Gaetani 1, G Ferrari 1, E Righi 1, S Bettelli 1, M Migaldi 1, P Ferrari 1, G P Trentini 1
PMCID: PMC501052  PMID: 10396236

Abstract

AIMS: To investigate the sensitivity of an in situ hybridisation system to detect human papillomavirus (HPV) infection in transitional cell bladder cancer and to evaluate the advantages of analysing multiple biopsies; to examine the correlation between HPV tumour infection detected by in situ hybridisation and the presence of serum anti-HPV antibodies detected by enzyme linked immunosorbent assay (ELISA); and to relate the presence of viral infection to grade, stage, and follow up in cases of bladder cancer. METHODS: The in situ hybridisation technique was used with broad spectrum and type specific (6/11, 16/18, 31/33/35) probes against HPV DNA in formalin fixed, paraffin embedded tissues from 43 cases of bladder cancer. The results were analysed for the presence and type of papillomavirus and correlated with clinicopathological variables. RESULTS: The presence of HPV DNA was identified by the in situ hybridisation technique in 17 of 43 cases of bladder cancer; 12 of these were serum antibody positive and 10 had had multiple biopsies. Fifteen of the cases that were negative for HPV DNA by in situ hybridisation had positive serum serology when tested by ELISA. In 14 cases, the HPV was either types 16/18 or types 31/33/35, both of which carry high oncogenic risk. The stage (p < 0.05) and grade (NS) of the tumour and the outcome on follow up (p < 0.05) were correlated with the presence of HPV infection. CONCLUSIONS: ELISA is not useful in identifying patients with HPV positive bladder cancer, but the use of several probes and multiple biopsies increases the detection rate of HPV in neoplastic tissues. The association between tumour virus infection and high grade/high stage tumours and worse outcome suggests that HPV infection of neoplastic tissue has a negative effect on the behaviour and evolution of transitional cell bladder carcinoma.

Full text

PDF
103

Images in this article

104Image
on p.104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aglianò A. M., Gradilone A., Gazzaniga P., Napolitano M., Vercillo R., Albonici L., Naso G., Manzari V., Frati L., Vecchione A. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int. 1994;53(3):125–129. doi: 10.1159/000282652. [DOI] [PubMed] [Google Scholar]
  2. Bryant P., Davies P., Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol. 1991 Jul;68(1):49–52. doi: 10.1111/j.1464-410x.1991.tb15256.x. [DOI] [PubMed] [Google Scholar]
  3. Chang F., Lipponen P., Tervahauta A., Syrjänen S., Syrjänen K. Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction. J Urol. 1994 Nov;152(5 Pt 1):1429–1433. doi: 10.1016/s0022-5347(17)32437-0. [DOI] [PubMed] [Google Scholar]
  4. Chetsanga C., Malmström P. U., Gyllensten U., Moreno-Lopez J., Dinter Z., Pettersson U. Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer. 1992 Mar 1;69(5):1208–1211. doi: 10.1002/cncr.2820690523. [DOI] [PubMed] [Google Scholar]
  5. Del Mistro A., Koss L. G., Braunstein J., Bennett B., Saccomano G., Simons K. M. Condylomata acuminata of the urinary bladder. Natural history, viral typing, and DNA content. Am J Surg Pathol. 1988 Mar;12(3):205–215. doi: 10.1097/00000478-198803000-00006. [DOI] [PubMed] [Google Scholar]
  6. Furihata M., Inoue K., Ohtsuki Y., Hashimoto H., Terao N., Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 1993 Oct 15;53(20):4823–4827. [PubMed] [Google Scholar]
  7. Gopalkrishna V., Srivastava A. N., Hedau S., Sharma J. K., Das B. C. Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med. 1995 Aug;71(4):231–233. doi: 10.1136/sti.71.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kalantari M., Karlsen F., Johansson B., Sigurjonsson T., Wärleby B., Hagmar B. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997 Aug;28(8):899–904. doi: 10.1016/s0046-8177(97)90004-6. [DOI] [PubMed] [Google Scholar]
  9. Kamel D., Päkkö P., Pöllänen R., Vähäkangas K., Lehto V. P., Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS. 1995 May;103(5):331–338. doi: 10.1111/j.1699-0463.1995.tb01116.x. [DOI] [PubMed] [Google Scholar]
  10. Kerley S. W., Persons D. L., Fishback J. L. Human papillomavirus and carcinoma of the urinary bladder. Mod Pathol. 1991 May;4(3):316–319. [PubMed] [Google Scholar]
  11. Kim K. H., Kim Y. S. Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers. Yonsei Med J. 1995 Sep;36(4):322–331. doi: 10.3349/ymj.1995.36.4.322. [DOI] [PubMed] [Google Scholar]
  12. Knowles M. A. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res. 1992;20(4):297–301. doi: 10.1007/BF00300263. [DOI] [PubMed] [Google Scholar]
  13. LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res. 1995 Apr;1(4):435–440. [PubMed] [Google Scholar]
  14. Lancaster W. D., Castellano C., Santos C., Delgado G., Kurman R. J., Jenson A. B. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol. 1986 Jan;154(1):115–119. doi: 10.1016/0002-9378(86)90405-9. [DOI] [PubMed] [Google Scholar]
  15. Lopez-Beltran A., Escudero A. L. Human papillomavirus and bladder cancer. Biomed Pharmacother. 1997;51(6-7):252–257. doi: 10.1016/s0753-3322(97)83540-8. [DOI] [PubMed] [Google Scholar]
  16. Lopez-Beltran A., Muñoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology. 1995 Jun;26(6):565–569. doi: 10.1111/j.1365-2559.1995.tb00276.x. [DOI] [PubMed] [Google Scholar]
  17. Maloney K. E., Wiener J. S., Walther P. J. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J Urol. 1994 Feb;151(2):360–364. doi: 10.1016/s0022-5347(17)34949-2. [DOI] [PubMed] [Google Scholar]
  18. Mvula M., Iwasaka T., Iguchi A., Nakamura S., Masaki Z., Sugimori H. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol. 1996 Feb;155(2):471–474. [PubMed] [Google Scholar]
  19. Noel J. C., Thiry L., Verhest A., Deschepper N., Peny M. O., Sattar A. A., Schulman C. C., Haot J. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology. 1994 Nov;44(5):671–675. doi: 10.1016/s0090-4295(94)80202-5. [DOI] [PubMed] [Google Scholar]
  20. Park T. W., Fujiwara H., Wright T. C. Molecular biology of cervical cancer and its precursors. Cancer. 1995 Nov 15;76(10 Suppl):1902–1913. doi: 10.1002/1097-0142(19951115)76:10+<1902::aid-cncr2820761306>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  21. Saltzstein D. R., Orihuela E., Kocurek J. N., Payne D. A., Chan T. S., Tyring S. K. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res. 1993 Mar-Apr;13(2):423–425. [PubMed] [Google Scholar]
  22. Sano T., Sakurai S., Fukuda T., Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int. 1995 Jul;45(7):506–512. doi: 10.1111/j.1440-1827.1995.tb03493.x. [DOI] [PubMed] [Google Scholar]
  23. Tenti P., Zappatore R., Romagnoli S., Civardi E., Giunta P., Scelsi R., Stella G., Carnevali L. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol. 1996 Jan;178(1):65–70. doi: 10.1002/(SICI)1096-9896(199601)178:1<65::AID-PATH451>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  24. Wilczynski S. P., Oft M., Cook N., Liao S. Y., Iftner T. Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Hum Pathol. 1993 Jan;24(1):96–102. doi: 10.1016/0046-8177(93)90068-r. [DOI] [PubMed] [Google Scholar]
  25. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–156. doi: 10.1007/978-3-642-78487-3_8. [DOI] [PubMed] [Google Scholar]
  26. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 1989 Sep 1;49(17):4677–4681. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES